Evaluation of Laparoscopic Peritoneal Lavage for Perforated Diverticulitis: A National Registry - Based Study

Sponsor
Uppsala University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT05893095
Collaborator
Uppsala University (Other)
52,863
78

Study Details

Study Description

Brief Summary

The goal of this observational study is to study the emergency surgical treatment of diverticular disease in Sweden outside clinical trials. The main questions it aims to answer are:

  • Which is the preferred surgical method of acute diverticular disease in Sweden?

  • Which are the short and long-term outcomes of the different surgical methods?

Researchers will compare the different methods to see if there is a surgical operation that is superior for the treatment of acute diverticulitis.

Detailed Description

A retrospective study of patients who were admitted to a Swedish hospital between 1st July 2014 and 31st December 2020 with an ICD-10 code for diverticular disease of the large intestine (K57.2- K57.9) will be included. Patients who underwent procedures relevant to diverticulitis will be identified and therefore will be included. Procedures will be grouped into two categories: Laparoscopic peritoneal lavage (Group I), and sigmoid resection with or without stoma (Group II).

The cohort will be studied from 1st January 1997 until the index date aiming to assess comorbidities, previous abdominal surgeries, and admissions for diverticular disease. A Charlson Comorbidity Index (CCI) system adjusted for Swedish ICD-10 version will be used to calculate a composite score to reflect comorbidity.

Study Design

Study Type:
Observational
Actual Enrollment :
52863 participants
Observational Model:
Other
Time Perspective:
Retrospective
Official Title:
Evaluation of Laparoscopic Peritoneal Lavage for Perforated Diverticulitis: A National Registry - Based Study
Study Start Date :
Jul 1, 2014
Actual Primary Completion Date :
Dec 31, 2020
Actual Study Completion Date :
Dec 31, 2020

Outcome Measures

Primary Outcome Measures

  1. Preferred operation for acute colonic diverticular disease [Up to 78 months]

    Laparoscopic peritoneal lavage or sigmoid resection

Secondary Outcome Measures

  1. Crossover surgery [1 day]

    Crossover from laparoscopy to resection surgery

  2. Reoperation [From date of inclusion until the date of the end of study or date of death from any cause, whichever came first, assessed up to 78 months]

    Disease- associated reoperations involving the bowel or abdominal wall

  3. Overall survival [From date of inclusion until the date of the end of study or date of death from any cause, whichever came first, assessed up to 78 months]

  4. Postoperative length of hospital stay [From date of inclusion until the date of discharge, assessed up to 78 months]

  5. Colorectal cancer diagnosis [From date of inclusion until the date of the end of study or date of death from any cause, whichever came first, assessed up to 78 months]

  6. Thirty-day postoperative mortality [Up 30 days]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • All patients aged 18 years or older who were admitted to a Swedish hospital between 1st July 2014 and 31st December 2020 with an ICD-10 code for diverticular disease of the large intestine (K57.2- K57.9).

  • Emergency admissions.

  • Patients who underwent procedures relevant to diverticulitis.

Exclusion Criteria:
  • Patients who were diagnosed with colorectal cancer before the index date.

  • Patients with synchronous operations that are supposed to be irrelevant to acute diverticulitis.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Uppsala University Hospital
  • Uppsala University

Investigators

  • Principal Investigator: Christos Kollatos, MD, Uppsala University Hospital, Sweden

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Christos Kollatos, MD, Uppsala University Hospital
ClinicalTrials.gov Identifier:
NCT05893095
Other Study ID Numbers:
  • 2021-01441
First Posted:
Jun 7, 2023
Last Update Posted:
Jun 7, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Christos Kollatos, MD, Uppsala University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 7, 2023